Bridging Innovators: Wallonia-UK Advanced Therapies Mission 2024

30 Sept – 3 Oct 2024 | United Kingdom

Jean-Luc Henrioul

COO

SEQALIS

Gosselies, Belgium

Walloon Participant

Analytical service provider with Cytogenomics platform for QC in ATMPS (eg. genomic stability of cell therapies, transgene insertion sites for gene therapies) and qTCR seq for Tcell immune system response studies of immunotherapy treatments.

About me

Analytical service provider upon state-of-the-art platforms such as a quantitative TCR Seq seamless analysis solution, several complementary cytogenomics technologies for the control of the genomic stability and the integrity of ATMPs, and an anatomo-pathology service in the neoantigen cancer vaccines and immuno-oncology fields.

My organisation

SEQALIS

Social media

Interests

  • Innovation in Life Sciences